and Erem Bilensoy

Dr. and Erem Bilensoy

Department of Pharmaceutical Technology, Faculty of Pharmacy, Hacettepe University, Ankara, Turkey

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 October 2017 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
GVGamze Varan
Gamze Varan
CVCem Varan
Cem Varan
NENazlı Erdoğar
Nazlı Erdoğar
AHA. Atilla Hıncal
A. Atilla Hıncal
and Erem Bilensoyand Erem Bilensoy
and Erem Bilensoy

1 April 2009 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
and Erem Bilensoyand Erem Bilensoy
and Erem Bilensoy
CSCan Sarisozen
Can Sarisozen
GEGunes Esendagli
Gunes Esendagli
ADA. Lale Doğan
A. Lale Doğan
YAYeşim Aktaş
Yeşim Aktaş
NMN. Aydın Mungan
N. Aydın Mungan

1 January 2008 in International Journal of Pharmaceutics
Verified
Journal Article
Closed access
and Erem Bilensoyand Erem Bilensoy
and Erem Bilensoy
OGOya Gürkaynak
Oya Gürkaynak
ADA. Lale Doğan
A. Lale Doğan
AHA. Atilla Hıncal
A. Atilla Hıncal

6 May 2010 in Expert Opinion on Drug Delivery
Verified
Journal Article
Closed access
and Erem Bilensoyand Erem Bilensoy
and Erem Bilensoy
Importance of the field: The lack of selective delivery of therapeutic molecules to cancer cells remains a problem in cancer therapy. As a result of this non-selectivity, cytotoxic agents are delivered to both healthy and cancerous cells, resulting in severe side effects for the patient, eventually causing termination of therapy or ineffective therapy resulting in progression or recurrence of the disease. In this context, cationic polymers with net positive surface charge emerge as a promising option owing to their very strong cellular interaction properties and good cellular uptake.Areas covered in this review: In this review, the structure, characteristics and preparation techniques for cationic nanoparticulate drug delivery systems are discussed in the light of cytotoxicity associated with cationic polymers and strong complement activation properties of cationic carrier systems on injection. In vivo behavior and biodistribution of cationic nanoparticles are also reviewed for a better understanding of b...

1 June 2005 in Journal of Controlled Release
Verified
Journal Article
Closed access
and Erem Bilensoyand Erem Bilensoy
and Erem Bilensoy
IVImran Vural
Imran Vural
ABAmélie Bochot
Amélie Bochot
JRJack Michel Renoir
Jack Michel Renoir
DDDominique Duchene
Dominique Duchene
AHA. Atilla Hıncal
A. Atilla Hıncal

11 March 2019 in Recent Advances in Drug Delivery and Formulation
Verified
Journal Article
Closed access
PDF file
NENazlıı Erdoğar
Nazlıı Erdoğar
SASafiye AKKIN
Safiye AKKIN
and Erem Bilensoyand Erem Bilensoy
and Erem Bilensoy
Objective: It is known that nanoparticulate drug delivery systems comprise a wide variety of dosage forms including nanospheres, micelles, solid lipid nanoparticles, nanoliposomes, dendrimers, magnetic nanoparticles, and nanocapsules. Methods: This review describes nanocapsule preparation techniques and their applications for the treatment of several diseases using patents and examples from the literature. Results: Nanocapsules are vesicular systems consisting of an inner liquid core (aqueous/oily) surrounded by a polymeric wall that have immense potential as drug carriers because of the many advantages like improving poor aqueous solubility, stabilizing drugs by protecting the molecule from the environment, providing the desired pharmacokinetic profile, allowing controlled release, as well as facilitating oral administration. Conclusion: The present study discusses and summarizes patents related to preparation methods of and recent studies from the last 10 years on nanocapsules as drug delivery systems.